Finland· FI-REL-REL7889
Ospolot
A sultiame product, registered in Finland by Bayer AG. The same ATC class is registered in 12 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Sultiame is registered in 12 of 19 countries.
Countries holding a registration under ATC N03AX03 (sultiame), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Sultiame · ATC N03AX03
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of sultiame costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sultiame · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$4.91
The record
At a glance
Fimea (Finland)- Manufacturer
- Bayer AG
- Country
- Finland (FI)
- ATC code
- N03AX03
- ATC class
- Sultiame
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
12 interactions on record for sultiame.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sultiame · interactions on record
12 records
12 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under N03AX03
Sultiame, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/017e3c93-e95a-4948-ad72-f8a1c2335ba5 GET /v1/drugs/017e3c93-e95a-4948-ad72-f8a1c2335ba5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.4",
"form": "tabletti",
"route": null,
"ddd_unit": "g",
"strength": "200 mg",
"atc_label": "sultiaami",
"ma_number": "3547",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL7889",
"authorised_at": "1966-06-01"
}See everything about sultiame.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.